Harpoon Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage includes a Q&A section on Harpoon Therapeutics Inc. This assessment of Harpoon Therapeutics Inc was prepared by All Street Sevva using leading Cognitive Robots. Full Sustainability analysis of Harpoon Therapeutics Inc can be reached by signing in.
Harpoon Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Harpoon Therapeutics Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Harpoon Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Harpoon Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Harpoon Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Harpoon Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Harpoon Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Harpoon Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Harpoon Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Harpoon Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Harpoon Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Harpoon Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Harpoon Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Harpoon Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Harpoon Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Harpoon Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Harpoon Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Harpoon Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Harpoon Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Harpoon Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.